Core Viewpoint - FinVolution Group, a leading fintech platform, is set to report its first quarter 2025 unaudited financial results on May 20, 2025, after U.S. market close, with a conference call scheduled for the same day at 8:30 PM ET [1]. Group 1: Earnings Call Details - The earnings conference call will be accessible via various dial-in numbers for participants in the United States, Canada, and internationally, with specific instructions to connect to the call for "FinVolution Group" [2]. - A live and archived webcast of the conference call will be available on the Company's investor relations website, with a replay accessible approximately one hour after the live call until May 27, 2025 [3]. Group 2: Company Overview - FinVolution Group is recognized as a leading fintech platform in China, Indonesia, and the Philippines, connecting young borrowers with financial institutions [4]. - Established in 2007, the Company is a pioneer in China's online consumer finance industry, leveraging innovative technologies in credit risk assessment, fraud detection, big data, and artificial intelligence [4]. - As of December 31, 2024, FinVolution Group had 208.3 million cumulative registered users across its operational regions [4].

Core Viewpoint - Innovative Food Holdings, Inc. (IVFH) is set to hold an investor call on May 15, 2025, to discuss its first quarter financial results for the period ending March 31, 2025 [1][2]. Company Overview - IVFH specializes in gourmet specialty foods, connecting artisan food makers with professional chefs across the nation [3]. - The company aims to enhance meal experiences by providing access to unique and trend-forward food products [3]. Investor Call Details - The investor call will take place at 10:00 am Eastern Time, featuring a question-and-answer session for participants [2]. - Interested parties can join the call via Zoom, which facilitates easier interaction through its "raise hand" feature [2].

Reports Solid First Quarter Results with Net Investment Income of $0.35 Per Share and a Net Asset Value of $29.66 Per Share Declared a Distribution of $0.36 Per Share for the Second Quarter of 2025 Successfully Exited its Equity Investment in GA Communications, Inc., Further Reducing the Company’s Non-Yielding Equity Portfolio Investors are Encouraged to Vote FOR the Merger with Portman Ridge Finance Corporation (“PTMN”) NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Logan Ridge Finance Corporation (“Logan Ri ...

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, May 08, 2025 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a growing home health care organization, is pleased to announce the release of financial results for the quarter ended March 31, 2025. All amounts are in United States dollars unless otherwise specified. Nova Leap Q1 2025 Financial Results Financial results for the first quarter ended March 31, 2025 ...

Reports Net Investment Income of $0.47 Per Share and Net Asset Value of $18.85 Per Share Deployment of Approximately $17.5 Million and Sales and Repayments of Approximately $15.7 Million for Net Deployment of Approximately $1.8 Million Announces Second Quarter 2025 Quarterly Base Distribution of $0.47 Per Share Investors are Encouraged to Vote FOR the Acquisition of Logan Ridge Finance Corporation NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Portman Ridge Finance Corporation (Nasdaq: PTMN) (the “Company” or ...

MISSISSAUGA, Ontario, May 08, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months ended March 31, 2025 on Thursday, May 15, 2025 after market hours. A presentation on the Company’s first quarter 2025 results by René Goehrum, BioSyent President and CEO, will also be available on the Company’s website on the date of release. About BioSyent Inc. Listed on the TSX Venture Exchange under the trading symbol “RX”, BioSyent ...

RESEARCH TRIANGLE PARK, N.C., May 08, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its first quarter 2025 financial results before the opening of the U.S. financial markets on Tuesday, May 13, 2025. Management will host a conference call and webcast that day to discuss the Company’s financial and business results. Conference Call & Webcast Detail: Date:Tuesday, May 13, 2025Tim ...

Data cutoff date for Phase 2b NAVIGATE trial efficacy reached on April 30, 2025; top-line data readout expected in late June 2025Nature Microbiology publication highlights preclinical data and the potential of CD388 as a potent, universal antiviral for influenza prevention in healthy and high-risk populations regardless of immune statusConference call and webcast today at 5:00 PM Eastern Time SAN DIEGO, May 08, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology ...

TEJON RANCH, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Tejon Ranch Co., or the Company, (NYSE:TRC), a diversified real estate development and agribusiness company, today announced financial results for the three-months ended March 31, 2025. “Tejon Ranch is a one-of-a-kind asset, and I’m honored to take the helm of this incredible company,” said Matthew H. Walker, who assumed the duties of President and CEO of Tejon Ranch Co. on April 1, 2025. “Our first quarter results highlight the consistency of our long-t ...

Continues to Execute Strategic Initiatives to Accelerate Long-Term Profitable Growth Promotes Industry Veteran Tripp Wyckoff to Lead Adventure Entered into Agreement to Divest PIEPS Snow Safety Brand for €7.8 Million SALT LAKE CITY, May 08, 2025 (GLOBE NEWSWIRE) -- Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a global company focused on the outdoor enthusiast markets, reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Summary vs. Same Ye ...